Lipase Increased, Pancreatitis
Conditions
Brief summary
Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involvement such as abdominal pain, nausea, vomiting and diarrhea are also common. In this study, it was aimed retrospective analysis of clinical and laboratory data of patients who developed pancreatic injury and acute pancreatitis in the course of COVID 19 disease.
Interventions
OTHERAge, gender, hospitalization and mortality rates will be compared
Age, gender, hospitalization and mortality rates will be compared
Sponsors
Uşak University
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Inclusion criteria
* Patients with lipase levels measured during COVID-19
Exclusion criteria
Patients with age \<18 years Patients with pregnancy Patients whose lipase levels were not measured in the course of COVID-19 Patients with known solid organ malignacy Patients with known hematologic malignacy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The frequency of lipase enzyme elevation will be compared | From 31th March 2020 until 9th July 2021 |
| The mortaliy rate will be compared | From 31th March 2020 until 9th July 2021 |
Countries
Turkey (Türkiye)
Outcome results
None listed